Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study

European Heart Journal

Volumn 26, Issue 24, 2005, Pages 2689-2697

  Jost, Andreas ^a   Rauch, Bernhard ^a   Hochadel, Matthias ^a   Winkler, Ralph ^a   Schneider, Steffen ^a   Jacobs, Martina ^a   Kilkowski, Caroline ^a   Kilkowski, Andreas ^a   Lorenz, Herbert ^a   Muth, Kerstin ^a   Zugck, Christian ^b   Remppis, Andrew ^b   Haass, Markus ^c   Senges, Jochen ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Theresienkrankenhaus   (Germany)

Author keywords

Beta blocker; Chronic systolic heart failure; MERIT HF study; Prognosis; Registry

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; METOPROLOL; METOPROLOL SUCCINATE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BYPASS SURGERY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; REGISTRIES; SURVIVAL ANALYSIS;

EID: 28544437133     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi473     Document Type: Article

References (13)

1. Remme WJ and Swedberg K (Co-chairmen), Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-1560.
2. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee to revise the 1995 guidelines for the evaluation and management of heart failure). Circulation 2001;104:2996-3007.
3. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007.
4. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomized trial. Lancet 1999;353:9-13.
5. Packer M, Coats AJS, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL, for the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1659-1665.
6. The Beta-Blocker Evaluation of Survival Trial Investigators. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 2001;344:1659-1667.
7. Masoudi FA, Havranek EP, Wolfe P, Gross CP, Rathore SS, Steiner JF, Ordin DL, Krumholz HM. Most hospitalized older persons do not meet the enrolment criteria for clinical trials in heart failure. Am Heart J 2003;146:250-257.
8. Van Bergen PF, Jonker JJ, Molhoek GP, van der Burgh PH, van Domburg RT, Deckers JW, Hofman A. Characteristics and prognosis of non-participants of a multi-centre trial of long-term anticoagulant treatment after myocardial infarction. Int J Cardiol 1995;49:135-141.
9. Albert SM, Sano M, Marder K, Jacobs DM, Brandt J, Albert M, Stern Y. - Participation in clinical trials and long-term outcomes in Alzheimer's disease. Neurology 1997;49:38-43.
10. Andersen PK. Testing goodness of fit of Cox's regression and life model. Biometrics 1982;38:67-77.
11. Cleland JG, Cohen-Solal A, Cosin Aguilar J, Dietz R, Eastaugh J, Follath F, Freemantle N, Gavazzi A, van Gilst WH, Hobbs FDR, Korewicki J, Madeira HC, Preda I, Swedberg K, Widimsky J, for the IMPROVEMENT of Heart Failure Programme Committees and Investi Cleland JGF. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 2002;360: 1631-1639.
12. J. Gonseth J, Guallar-Castillon P, Banegas JR. The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports. Eur Heart J 2004;25:1570-1595.
13. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2005; http://www.goldcopd.com